PMA device
Avitene Flowable Collagen Hemostat
Davol Inc., Sub. C. R. Bard, Inc. · Agent, Absorbable Hemostatic, Collagen Based (LMF, Class III) · First FDA decision Dec 18, 2024, newest Jun 10, 2025Surgical bleeding and hemostasis
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
PMA pathway
Device trials
3
Naming "Avitene Flowable"
MAUDE reports
0
Brand "Avitene Flowable", since 2015
PubMed studies
0
Mentioning "Avitene Flowable"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Avitene Flowable Collagen Hemostat
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
- Avitene Flowable Collagen HemostatPMA supplement
N17600-S043 · Decided Jun 10, 2025 · 89 days after receipt · Normal 180 Day Track
Device type: Agent, absorbable hemostatic, collagen based (LMF) · General & Plastic Surgery
- Avitene Flowable Collagen HemostatPMA supplement
N17600-S040 · Decided Dec 18, 2024 · 183 days after receipt · Normal 180 Day Track
Device type: Agent, absorbable hemostatic, collagen based (LMF) · General & Plastic Surgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Avitene Flowable", any status and sponsor, newest update first.
Universidad de Especialidades Espiritu SantoAcademic, hospital or other
NCT06593275 · 12 participants · Start Oct 30, 2023 · Primary completion Feb 15, 2025
Device: Flowable Resin Composite Palatal Barrier; Self-Adhesive Oral Dressing · For: Perception of Pain; Protection of the Palate
Sites: Samborondón, Ecuador
Andrea RavidaAcademic, hospital or other
NCT06944639 · 25 participants · Start Apr 28, 2025 · Primary completion Jun 25, 2026
Device: Membrane Jason MB GmbH Non-cross-linked (NCL); Membrane BioMend Extend Glutaraldehyde cross-linked and 1 more · For: Bone Regeneration
Sites: Pittsburgh, Pennsylvania
- The Omeza Protocol for Chronic UlcersStatus unknown
Omeza, LLCNot on our public-company list
NCT04198441 · 78 participants (planned) · Start Jun 2, 2020 · Primary completion Oct 2021
Device: Wound dressing · For: Venous Leg Ulcer; Diabetic Foot Ulcer
Sites: Jacksonville, Florida; Newark, New Jersey; Portland, Oregon · 4 sites in all
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Avitene Flowable", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code LMF
1,445 reports: 207 malfunction, 1,171 injury, 61 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Avitene Flowable"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code LMF.
- SURGIFOAM® Absorbable Gelatin SpongeFerrosan Meidcal Devices A/S · PMA 2026
- Floseal Hemostatic MatrixBaxter Healthcare Corp · PMA 2015
- Vitagel Surgical HemostatStryker Corp. · PMA 2013
- SURGIFLO Hemostatic Matrix Kit with ThrombinFerrosan Meidcal Devices A/S · PMA 2025
- Helistat Absorbable Collagen Hemostatic Sponge/OraFOAM Absorbable Collagen Hemostatic SpongeIntegra LifeSciences Corporation · PMA 2019
- Instat Collagen Absorbable HemostatETHICON, Inc. · PMA 2007
- Collastat Absorbable Collagen Hemostatic AgentsIntegra LifeSciences Corporation · PMA 2009
- Floseal (R) Matrix Hemostatic Sealant and Proceed (Tm) Hemostatic SealantBaxter Healthcare Corp · PMA 2001
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.